- Eric Hahnen, PhD and Jan Hauke, PhD, Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; Karen Gelmon, MD, BC Cancer, Vancouver, BC, Canada; Frederik Marmé, MD, Universitätsfrauenklinik, Mannheim, Germany; Corinna Ernst, PhD, Center for Familial Breast and Ovarian Cancer and, Center for Integrated Oncology (CIO), Cologne, Faculty of Medicine and, University Hospital Cologne, Cologne, Germany; Miguel Martin, MD, Instituto de Investigacion Sanitaria Gregorio Marañon, CIBERONC, Universidad Complutense, Madrid, Spain; Michael Untch, MD, Helios Kliniken, Berlin-Buch, Germany; Hervé Bonnefoi, MD, Institut Bergonié, Université de Bordeaux INSERM U916, Bordeaux, France; Erik Knudsen, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY; Seock-Ah Im, MD, Seoul National University Hospital, Seoul, Korea; Angela DeMichele, MD, Penn Medicine Abramson Cancer Center, Philadelphia, PA; Laura Van’t Veer, MD, University of California, San Francisco, CA; Sung-Bae Kim, MD, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Harry Bear, MD, PhD, Division of Surgical Oncology, Massey Comprehensive Cancer Center, Virginia Commonwealth University, VCU Health, Richmond, VA; Nicole McCarthy, MD, Breast Cancer Trials Australia and New Zealand, University of Queensland, Brisbane, Australia; Kerstin Rhiem, MD, Center for Familial Breast and Ovarian Cancer and, Center for Integrated Oncology (CIO), Cologne, Faculty of Medicine and, University Hospital Cologne, Cologne, Germany; Nicole McCarthy, MD, The Institute of Cancer Research, Royal Cancer Hospital, London, United Kingdom; Agnieszka Witkiewicz, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY; Federico Rojo, MD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Martin Filipits, MD, Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Lesley-Ann Martin, MD, Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom; Peter A. Fasching, MD, Universitätsklinik Erlangen, Erlangen, Germany; Christian Schem, MD, Mammazentrum Hamburg, Hamburg, Germany; Kerstin Becker, PhD, Cologne Center for Genomics, Medical Faculty, University of Cologne, Cologne, Germany; José A. García-Sáenz, MD, Service de Oncología Médica, Hospital Clínico San Carlos, Madrid, Spain; Catherine M. Kelly, MD, Trinity St James's Cancer Centre at St James's Hospital, Dublin, Ireland; Toralf Reimer, MD, Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany; Masakazu Toi, MD, Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Hope S. Rugo, MD, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Carsten Denkert, MD, Institut für Pathologie, Philipps-Universität Marburg, Marburg, Germany; Michael Gnant, MD, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Andreas Makris, MD, Mount Vernon Cancer Centre, Northwood, United Kingdom; Yuan Liu, MD and Olga Valota, MSc, Pfizer, Pfizer Italia s.r.l., Milan, Italy; Bärbel Felder, PhD; Karsten Weber, PhD, Valentina Nekljudova, PhD; and Sibylle Loibl, MD, German Breast Group (GBG), Neu-Isenburg, Germany
Corresponding author: Eric Hahnen, PhD; e-mail:
[email protected].
